CONTACT US: 905-458-6650 | EMAIL:
PCCN Brampton

Dr. Andrew Loblaw, “The Promise of Stereotactic Ablative Radiotherapy (SABR) for Primary and Metastatic Prostate Cancer.”

Tuesday, 8 May 2018 – 7:00pm Dr. Loblaw’s presentation will review evidence supporting use of MRI-guided SABR for primary and metastatic prostate cancer discuss optimal patient selection factors for SABR discuss dosimetric predictors of SABR outcomes review current and future clinical trials of SABR We tend to take for granted that everybody knows Dr. Loblaw […]